Jinhai Medical Technology (2225.HK) Earnings Analysis
Jinhai Medical Technology (2225.HK) has no confirmed upcoming earnings date. Trailing P/E -207.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2225.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 2225.HK. This page updates as the calendar is published.
2225.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.00787 HKD | n/a | n/a | n/a |
| 2025-09-06 | -0.0122 HKD | n/a | n/a | n/a |
| 2024-08-30 | -0.00673 HKD | n/a | n/a | n/a |
2225.HK valuation and analyst view
| Trailing P/E | -207.96 |
|---|---|
| Trailing EPS | -0.00324 HKD |
| Price / book | 70.44 |
| Dividend yield | 0.00% |
| Market cap | 21.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jinhai Medical Technology (2225.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 2225.HK. This page updates as the calendar is published.
Did 2225.HK beat earnings last quarter?
Consensus estimate data was not available for 2225.HK's 2026-03-26 report.
What is 2225.HK's current P/E ratio and EPS?
2225.HK trades at a trailing P/E of -207.96 on trailing EPS of -0.0032448747625358427 HKD.
What do analysts rate 2225.HK?
2225.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.